What clinical trials are available for recurrent Breast Cancer

Clinical Trials for Recurrent Breast Cancer

I appreciate your question about clinical trial options. While I have access to comprehensive NCCN Guidelines for breast cancer treatment, the specific clinical trial information in my current resources focuses primarily on pancreatic cancer trials rather than breast cancer-specific trials.

However, I can provide you with important context about how clinical trials fit into recurrent breast cancer care, and direct you to the best resources for finding active trials.

Why Clinical Trials Matter for Recurrent Breast Cancer

According to the NCCN Guidelines for Invasive Breast Cancer, when you have recurrent or metastatic (stage IV) breast cancer, your care team will:

• Re-test your cancer to identify specific biomarkers (genetic mutations in your tumor)
• Evaluate you for targeted therapies based on findings like PIK3CA, AKT1, PTEN, ESR1, NTRK, and RET mutations
• Consider clinical trials as part of your treatment options, especially if your cancer has specific molecular characteristics

The NCCN Guidelines emphasize that clinical trials are particularly valuable because they may offer access to newer treatment combinations or approaches not yet available as standard care.

How to Find Breast Cancer Clinical Trials

The most authoritative resources for finding active clinical trials are:

1. ClinicalTrials.gov (National Cancer Institute)

   • Search for "breast cancer" + "recurrent" or "metastatic"
   • Filter by location, trial phase, and recruitment status
   • This is the official U.S. registry of all clinical trials

2. NCCN Patient Guidelines for Metastatic Breast Cancer

   • Available at NCCN.org/patientguidelines
   • Includes information about discussing clinical trial options with your care team

3. Cancer.gov (National Cancer Institute)

   • Provides patient-friendly information about clinical trials
   • Explains what to expect and questions to ask

4. Your Oncology Team

   • They can identify trials specifically matched to YOUR tumor's biomarker profile
   • They know which trials are actively enrolling at your treatment center

Key Questions to Ask Your Oncologist About Clinical Trials

1. "Are there any clinical trials available for my specific breast cancer subtype and biomarker profile?"

   • (For example: HR-positive/HER2-negative with PIK3CA mutations, or triple-negative breast cancer)

2. "What is the trial testing, and how does it differ from standard treatment?"

3. "What are the potential benefits and risks of this trial compared to standard options?"

4. "How often would I need to visit the trial site, and what additional testing is involved?"

5. "Can I stop the trial if I experience side effects, and what happens to my care then?"

6. "Are there any costs to me for participating in this trial?"

Important Context from NCCN Guidelines

According to the NCCN Guidelines for Metastatic Breast Cancer, treatment decisions for recurrent disease should include:

• Comprehensive biomarker testing (including tumor tissue or blood-based testing)
• Discussion of all available options: standard therapies, clinical trials, and supportive care
• Shared decision-making between you and your care team about which approach fits your goals

The guidelines emphasize that "patients should be informed about the availability of clinical trials, including the risks and benefits of various treatments."

Next Steps

1. Request a biomarker report from your oncologist if you haven't received one recently
2. Ask specifically about clinical trials that match your tumor's characteristics
3. Visit ClinicalTrials.gov and search with your specific diagnosis and biomarkers
4. Bring a list of potential trials to your next appointment to discuss with your care team

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions about clinical trial participation.